Looking Beyond Mucosal Healing: Effect of Biologic Therapy on Transmural Healing in Pediatric Crohn's Disease

Background:Crohn's disease is a chronic inflammatory disease characterized by a progressive transmural bowel damage leading to complications. Anti-TNF&agr; therapy is effective in achieving mucosal healing (MH), but its efficacy on transmural inflammation has been poorly investigated. The aim of this study is to evaluate, in pediatric Crohn's disease, the efficacy of anti-tumor necrosis factor &agr; agents in inducing transmural healing (TH) as assessed by ultrasonography (US). Methods:Children with Crohn's disease requiring anti-tumor necrosis factor &agr; therapy were prospectively enrolled. Clinical activity, laboratory tests, endoscopic activity, and transmural disease assessed by small intestine contrast US (SICUS) were evaluated at baseline (T0) and then after 9 to 12 months of therapy (T1). We evaluated US quantitative and qualitative parameters: disease extension (centimeters), bowel wall (BW) thickness >3 mm, BW vascularity and stratification strictures, and prestenotic dilatation. TH was defined as a BW thickness <3 mm and normalization of all US parameters at T1. Results:Thirty-two patients were included. Patients with mucosal healing (MH) showed a significant decrease of BW thickness and disease extension at T1 (4.3 ± 1.4 mm and 8 ± 6.3 cm versus 6.1 ± 2.3 mm and 13 ± 5 cm at baseline, respectively) (P < 0.001). Increased vascularity of the BW was found in 80% of patients at T0 and in 18% at T1 (P < 0.001). These parameters did not change in patients without MH, despite clinical and laboratory remission. The presence of stenosis and prestenotic dilatation did not modify in any group. A complete TH was achieved in 14% of patients, all of them showing complete MH. Conclusions:Biologics induce clinical and laboratory remission and MH in pediatric CD. Although caution is needed due to the small sample size, our data suggest that transmural inflammation also improves during therapy, but a complete TH is achieved only in a small percentage of patients.

[1]  Silvia Bloise,et al.  Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort. , 2016, Journal of Crohn's & colitis.

[2]  S. Cucchiara,et al.  Use of Imaging Techniques in Inflammatory Bowel Diseases That Minimize Radiation Exposure , 2015, Current Gastroenterology Reports.

[3]  A. Szymczak,et al.  The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity , 2015, Abdominal Imaging.

[4]  G. Di Nardo,et al.  Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to evaluate the small bowel in pediatric Crohn's disease: a prospective, blinded, comparison study. , 2015, Gastrointestinal endoscopy.

[5]  E. Louis,et al.  Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease. , 2015, Gastroenterology.

[6]  N. Moreno,et al.  Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: changes following treatment with immunomodulators and/or anti-TNF antibodies. , 2014, Journal of Crohn's & colitis.

[7]  I. Ordás,et al.  Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. , 2014, Gastroenterology.

[8]  G. Veres,et al.  ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents , 2013, Journal of pediatric gastroenterology and nutrition.

[9]  P. Rutgeerts,et al.  Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. , 2013, Journal of Crohn's & colitis.

[10]  G. Di Nardo,et al.  Small intestine contrast ultrasonography in pediatric Crohn's disease. , 2013, The Journal of pediatrics.

[11]  P. Rutgeerts,et al.  Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial , 2013, Gut.

[12]  N. Caporaso,et al.  Transmural Healing Evaluated by Bowel Sonography in Patients with Crohn’s Disease on Maintenance Treatment with Biologics , 2013, Inflammatory bowel diseases.

[13]  J. Stoker,et al.  Serial Magnetic Resonance Imaging for Monitoring Medical Therapy Effects in Crohn’s Disease , 2013, Inflammatory bowel diseases.

[14]  G. Simonetti,et al.  Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  Jeroen A. W. Tielbeek,et al.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. , 2013, Journal of Crohn's & colitis.

[16]  E. Louis,et al.  Evolving Definitions of Remission in Crohn’s Disease , 2013, Inflammatory bowel diseases.

[17]  L. Peyrin-Biroulet,et al.  Moving towards disease modification in inflammatory bowel disease therapy , 2013, Current opinion in gastroenterology.

[18]  M. Salvatore,et al.  Noninvasive Diagnosis of Small Bowel Crohn’s Disease: Direct Comparison of Bowel Sonography and Magnetic Resonance Enterography , 2013, Inflammatory bowel diseases.

[19]  L. Peyrin-Biroulet,et al.  Deep Remission in Inflammatory Bowel Disease: Looking Beyond Symptoms , 2013, Current Gastroenterology Reports.

[20]  P. Rutgeerts,et al.  Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. , 2012, Gastroenterology.

[21]  M. Dądalski,et al.  The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn’s disease , 2012, European journal of gastroenterology & hepatology.

[22]  B. Ciccantelli,et al.  Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: A prospective comparative study versus intraoperative findings , 2010, Inflammatory bowel diseases.

[23]  J. Gisbert,et al.  Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[24]  H. Tilg,et al.  Development of the Crohn's disease digestive damage score, the Lémann score , 2010, Inflammatory bowel diseases.

[25]  L. Peyrin-Biroulet,et al.  The Natural History of Adult Crohn's Disease in Population-Based Cohorts , 2010, The American Journal of Gastroenterology.

[26]  P. Rutgeerts,et al.  Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. , 2010, Gastroenterology.

[27]  L. Peyrin-Biroulet,et al.  Clinical implications of mucosal healing for the management of IBD , 2010, Nature Reviews Gastroenterology &Hepatology.

[28]  P. Rutgeerts,et al.  Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.

[29]  Julia Salleron,et al.  Natural history of pediatric Crohn's disease: a population-based cohort study. , 2008, Gastroenterology.

[30]  Roelof J Bennink,et al.  Magnetic resonance imaging in Crohn's disease , 2008 .

[31]  G. Sebag,et al.  Ultrasonography of Crohn disease in children , 2007, Pediatric Radiology.

[32]  Salvatore Greco,et al.  Bowel ultrasound in Crohn's disease. , 2006, Best practice & research. Clinical gastroenterology.

[33]  G. Casazza,et al.  Role of US in detection of Crohn disease: meta-analysis. , 2005, Radiology.

[34]  R. Caprilli,et al.  Small Intestine Contrast Ultrasonography: An Alternative to Radiology in the Assessment of Small Bowel Disease , 2005, Inflammatory bowel diseases.

[35]  P. Rutgeerts,et al.  Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. , 2004, Gastrointestinal endoscopy.

[36]  F. Carbonnel,et al.  Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.